CoVID-19 vaccine

The Latest

  • Updated COVID-19 Vaccine Shows 54% Efficacy Against Symptomatic Infection, CDC Reports
    Vaccine
    According to a comprehensive study, individuals who received the updated shots exhibited a 54% lower risk of contracting the virus, showcasing the vaccine's effectiveness against contemporary variants, including the dominant JN.1 strain.
  • WHO Insists COVID-19 Outbreak In China Began Before Restrictions Eased
    Wuhan
    Before Beijing changed its rigorous zero-COVID policy, coronavirus infections were skyrocketing, according to emergencies director Mike Ryan
  • COVID-19 Vaccines For Young Children Start Rollout In U.S.
    VACCINE, BABY
    Opening up shots to those under the age of five is a watershed moment, but there are mixed feelings about this long-awaited phase of the immunization effort.
  • U.S. Panel Set To Authorize COVID Vaccine For Young Children
    Moderna
    Pfizer and Moderna vaccines use messenger RNA technology to deliver genetic code for the coronavirus spike protein to human cells.
  • Moderna Seeks Authorization for COVID-19 Vaccine for Very Young Children by End of April
    Moderna
    Moderna is hoping to get authorization to provide a pediatric COVID-19 vaccine with a low dose to children aged 6 months to under 6 years old.
  • Novavax COVID-19 Vaccine Gets Approval In Japan
    APPROVED
    The vaccine is manufactured and distributed in Japan by Takeda Pharmaceutical Co
  • Getting Vaccinated Against COVID-19 17 Times More Effective Than Natural Immunity: Study
    ENDEMIC
    For anyone doubting the vaccine, this should convince you.
  • COVID-19 Destroys Women's Placenta, Increases Risk Of Stillbirth
    PREGNANT WOMAN, NURSERY
    It's an uncommon outcome for any pregnancy but women with COVID-19 face an elevated risk.
  • South Africa Approves Chinese-Made Sinopharm COVID-19 Vaccine
    APPROVED
    Sinopharm and Sinovac's COVID-19 vaccines effective against the coronavirus's Delta variant.
  • Moderna Begins Trial On Omicron-Specific Booster Shot
    Moderna
    Moderna said it will be conducting mid-stage studies on its new Omicron-specific booster in the U.S.
1   2   3   4   5   6   7   8   9   10  Next